Anavex Life Sciences Corp. Announces Its Preclinical Pipeline Of Novel Oncology Therapies

February 12, 2007 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

KELOWNA, BRITISH COLUMBIA -- (MARKET WIRE) -- February 12, 2007 -- Anavex Life Sciences Corp. (the "Company") (OTCBB: AVXL) announces its strategic vision for growth by discovering and developing cutting-edge drugs against solid tumors.

Twitter
LinkedIn
Facebook
Email
Print

Preclinical

Anavex Life Sciences Corp.